Bacillus clausii: The Science Behind Endogermila®'s Antibiotic-Resistant Strains

Bacillus clausii is a spore-forming probiotic that tolerates several commonly prescribed antibiotics, which is why it's so often given during an antibiotic course. At ELMED Life Sciences, we supply it as Endogermila® oral suspension vials. The resistance it carries is intrinsic, meaning the genes sit on the bacterial chromosome, and that detail is what makes it clinically acceptable.

Quick Answer

B. clausii survives certain antibiotics because its resistance genes are chromosomal. They aren't carried on plasmids or transposons, the mobile genetic elements responsible for most resistance spread between bacteria. Laboratory studies have not detected transfer of these genes to other species. Tolerance is strain-specific and limited to particular antibiotic classes, so it shouldn't be read as resistance to antibiotics in general.

What Is Bacillus clausii?

B. clausii is a Gram-positive, rod-shaped soil bacterium. Like other Bacillus species, it forms spores, a dormant state protected by a dense protein coat and a dehydrated core. Spores pass through gastric acid and bile largely intact and germinate into vegetative cells in the small intestine.

It's one of the most widely prescribed probiotics in Indian practice, typically supplied as spores in purified water in single-dose vials. Endogermila® follows this format. Each vial is a ready-to-use dose with nothing to measure, and it can be taken straight or mixed into water or milk.

Why Does a Probiotic Need Antibiotic Tolerance?

Antibiotics act on the pathogen and the commensal flora at the same time. The resulting dysbiosis, a disturbance in the normal balance of gut bacteria, is one of the main drivers of antibiotic-associated diarrhea (AAD).

Most probiotic strains are just as susceptible to these drugs as the gut flora they're meant to support. B. clausii stays viable through many antibiotic courses, so it can be co-prescribed from day one instead of waiting until treatment ends.

Which Antibiotics Does B. clausii Tolerate?

The most extensively studied B. clausii preparation combines four strains designated O/C, N/R, SIN and T. The designations largely reflect the antibiotics each strain was selected against. T refers to tetracycline, and N/R to novobiocin and rifampicin.

Published characterization of these strains reports tolerance to macrolides, chloramphenicol and some aminoglycosides, among other agents. The profile differs between strains, so it's worth confirming the strain designations on the label when you review a product.

Is a Resistant Probiotic Safe?

Prescribers and pharmacists ask us this more than anything else. The answer depends on whether the resistance can move.

Chromosomal vs transferable resistance

Resistance genes carried on plasmids or transposons can spread through horizontal gene transfer, most often by conjugation between neighboring bacteria. Chromosomal genes are far more stable. In B. clausii, genes such as erm(34), which confers macrolide resistance, have been mapped to the chromosome.

What the transfer studies show

Mating experiments have tested whether B. clausii can pass its resistance genes to other bacteria, including potential pathogens, and the published studies did not detect transfer. The gut is far more complex than a culture plate, so continued surveillance of resistant probiotic strains remains sound practice.

What Is Bacillus clausii Used For?

Clinical research on B. clausii has mainly focused on

• prevention of antibiotic-associated diarrhea
• acute infectious diarrhea in children, as an adjunct to oral rehydration solution (ORS) and zinc
• reducing gastrointestinal side effects during Helicobacter pylori eradication therapy

Some trials and reviews report shorter episodes of diarrhea, while others show little clear effect, and guidelines differ on where it fits. Rehydration and the antibiotic remain the core of treatment.

How Should It Be Taken With Antibiotics?

Despite its tolerance, many clinicians still advise a gap of a few hours between the antibiotic and the probiotic vial. Shake the vial well, take it straight or mixed into water or milk, and continue for the duration advised. Prescribers often keep the probiotic going for several days after the antibiotic ends to support recovery of the gut flora. The antibiotic course itself should never be cut short because a probiotic is being taken.

Who Should Use It With Caution?

B. clausii has a long safety record in healthy children and adults. The European Food Safety Authority includes it on its Qualified Presumption of Safety list, provided each strain is confirmed not to produce toxins. Rare cases of bacteremia have been reported, almost always in patients who were severely immunocompromised, critically ill or had a central venous catheter. In these groups, any probiotic should be used only under close medical supervision.

Key Takeaways

• B. clausii tolerates several antibiotic classes and can be co-prescribed from the start of treatment.
• Its resistance genes are chromosomal, and transfer studies have not detected gene spread.
• Tolerance is strain-specific and doesn't extend to every antibiotic.
• Most clinical research covers antibiotic-associated diarrhea and acute diarrhea in children, with mixed results.
• High-risk patients need medical supervision before starting it.

Final Thoughts

Intrinsic antibiotic tolerance gives B. clausii its particular place in practice, offering probiotic support while the gut flora is most disrupted. Its safety case rests on the chromosomal location of those genes and the transfer data published so far. Endogermila® is manufactured in GMP Certified and US FDA Registered facilities, and clinicians or brand owners who want strain details or private label options can reach the ELMED team directly.